SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -23.64M | -16.77M | -17.69M | -13.55M | -22.64M |
| Total Depreciation and Amortization | 2.76M | 2.24M | 3.05M | 3.39M | 2.85M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.97M | 1.05M | 695.00K | 1.76M | 2.38M |
| Change in Net Operating Assets | -624.00K | -1.79M | -9.83M | -12.37M | -4.46M |
| Cash from Operations | -14.53M | -15.27M | -23.77M | -20.76M | -21.88M |
| Capital Expenditure | 0.00 | -47.00K | -65.00K | -101.00K | -113.00K |
| Sale of Property, Plant, and Equipment | 15.00K | 155.00K | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 15.00K | 108.00K | -65.00K | -101.00K | -113.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 331.00K | 670.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | 331.00K | 670.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.52M | -15.16M | -23.84M | -20.53M | -21.32M |